October 14, 2020 From Andrea Maddox-Smith, CEO: Today’s news that Merck has announced construction of a new manufacturing facility to significantly expand its production capacity for TICE® BCG is welcome news for bladder cancer patients. We appreciate Merck’s commitment to increase the supply of a treatment that is in such
Bladder Cancer News
Bladder Cancer Advocacy Network Statement on Golfer John Daly’s Bladder Cancer Diagnosis
(September 11. 2020 BETHESDA, MD) – The Bladder Cancer Advocacy Network (BCAN) was saddened to learn of the bladder cancer diagnosis of professional golfer John Daly. According to an interview with the Golf Channel, Mr. Daly stated that he had recently been suffering from back pains and said these issues
2020 Information About the BCG Shortage
September 2020 Last year, BCAN and its partners shared a message regarding the global shortage of Merck’s TICE BCG due to an increasing global demand for the product. The American Urological Association (AUA), American Association of Clinical Urologists (AACU), Bladder Cancer Advocacy Network (BCAN), Society of Urologic Oncology (SUO), the
Introducing Ina®, the Intelligent Nutrition Assistant
BCAN has partnered with Savor Health® to bring personalized nutrition support to help people with bladder cancer eat healthily and stay well-nourished throughout treatment and beyond. Good nutrition can help people with cancer feel better and manage symptoms like diarrhea, nausea, tiredness, and decreased appetite. This service is Ina®, the
Bladder Cancer Advocacy Network Announces 2020 Bladder Cancer Research Innovation Awardee
$300,000 Award Fuels Bladder Cancer Research Innovation FOR IMMEDIATE RELEASE: (June 22, 2020: Bethesda, MD) Today, the Bladder Cancer Advocacy Network (BCAN) announced the recipient of its prestigious Bladder Cancer Research Innovation Award. This year’s awardee is Jeffrey Ravetch, MD, PhD, Professor and Head of the Laboratory of Molecular Genetics
BCAN Announces 2020 Bladder Cancer Research Innovation Awardee
BCAN’s Bladder Cancer Research Innovation Award supports exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer. The 2020 awardee is Jeffrey Ravetch, MD, Ph.D., Professor, and Head of the Laboratory of Molecular Genetics and Immunotherapy at Rockefeller University. Dr. Ravetch’s proposal is
The Bladder Cancer Advocacy Network Announces Awardees of Its 2020 New Discoveries Young Investigator Awards
Awardees recognized for novel, early career research that improves the understanding and treatment of bladder cancer FOR IMMEDIATE RELEASE: May 14, 2020 Bethesda, MD – The Bladder Cancer Advocacy Network (BCAN) today announced the recipients of its three New Discoveries Research Young Investigator Awards, supporting the development of outstanding early